Related Experiment Video
Updated: Dec 28, 2025
07:36
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
7.3K
Remodeling Translation Primes CD8+ T-cell Antitumor Immunity
Katie E Hurst1,2, Kiley A Lawrence1,2, Rob A Robino1,2
1Department of Orthopedics and Physical Medicine, Medical University of South Carolina, Charleston, South Carolina.
Cancer Immunology Research
|February 21, 2020
Summary
Interleukin-15 (IL15)-conditioned T cells enhance protein translation within tumors. Modulating T-cell protein translation, particularly CD8+ T cells, can significantly boost antitumor immunity for cancer immunotherapy.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Protein translation's role in T cell function and antitumor efficacy is not well understood.
- The metabolic energy sensor AMP-activated protein kinase influences T cell activity.
Purpose of the Study:
- To investigate the role of protein translation in T cell-mediated antitumor responses.
- To explore how modulating protein translation can enhance cancer immunotherapy.
Main Methods:
- Comparing protein translation in IL15-conditioned T cells versus effector T cells.
- Analyzing T cell protein translation capacity within tumor microenvironments.
- Investigating the effects of pharmacologic inhibition of translation elongation on T cell antitumor immunity.
Main Results:
- IL15-conditioned T cells showed reduced translation compared to effector T cells but enhanced translation within tumors.
- Effector T cells could not replicate the tumor-specific translation enhancement.
- Ex vivo inhibition of translation elongation significantly improved T cell antitumor immunity.
Conclusions:
- Altering protein translation in CD8+ T cells is a viable strategy to enhance their antitumor capabilities.
- Targeting protein translation offers a novel approach for improving cancer immunotherapy outcomes.
Related Concept Videos
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:22T Cell Activation and Clonal Selection
14.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.4K
01:27Cytotoxic T Cells-mediated Immune Response
6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K